MYC and osteosarcoma: Therefore, new therapeutic approaches are needed to improve therapeutic efficacy in osteosarcoma patients, and we hypothesize that the FAM83H might be involved in the oncogenesis of the osteosarcoma based on the role of FAM83H in cancer progression in conjunction with MYC and the β-catenin pathway.